安徽省庆云医药股份有限公司

安徽省庆云医药股份有限公司

安徽省合肥市双凤工业区金川路南025号

2008

80至89

不愿意公开

安徽省庆云医药股份有限公司成立于2003年，主营产品有瑞舒伐他汀钙、匹伐他汀钙、西洛多辛、罗替戈汀、盐酸雷诺嗪等中间体及原料药依达拉奉。下设研发中心合肥市梓熤科技贸易有限公司及生产基地滁州市庆云医药有限公司。滁州市庆云医药有限公司位于安徽省第二大化工园区——盐化工业园内，占地面积100亩，总设计4个生产车间，总面积达到1.9万平方米，其中仓储面积4000 m2，罐区总体积480 m³，污水处理能力达到500m³/天。一期总反应体积16.62万升。合肥市梓熤科技贸易有限公司注册资本300万人民币，主要从事精细化工产品、药品及相关产品的研究开发、生产销售、技术转让、技术咨询及服务，总面积30000平方米，配有Mass，HPLC，GC，IR，UV等分析检测仪器，同时也配备了药品稳定试验箱，光照培养箱等质量考察设备。

经验丰富的研发人员,生产能力,产品线丰富,接受小额订单,良好的信誉,优质服务

231131

www.qingyunchem.com

制造商

中国,中/南美洲,西欧,东欧,中东,亚洲

Rosuvastatin Calcium（147098-20-2）;Pitavastatin Calcium（147526-32-7）;Silodosin（160970-54-7）;Ranolazine HCI （95635-56-6）;Amlexanox （68302-57-8）;Betaxolol HCl （63659-19-8）;Rotigotine HCl （125572-93-2）;4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-methanol （147118-36-3）(147118-36-3);4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidine-5-carboxaldehyde/ 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl- N-methylsulfonyl)amino]pyrimidinyl-5-yl-formyl (147118-37-4) (147118-37-4);tert-Butyl Rosuvastatin ( 355806-00-7);tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2-dimethyl-1,3-dioxane-4-acetate (289042-12-2);2-[(4R,6S)-6-(Acetoxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid tert-butyl ester (154026-95-6);tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate (124752-23-4);tert-butyl 2-((4R,6S)-2,2-dimethyl-6-(((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)methyl)-1,3-dioxan-4-yl)acetate (1326302-97-9);N-[5-(bromomethyl)-4-(4-fluorophenyl)-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-Methanesulfonamide 5-(Bromomethyl)-4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidine (799842-07-2);N-[5-(Diphenylphosphinoylmethyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl]-N-methylmethanesulfonamide (289042-10-0 );[[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide (885477-83-8);2-Cyclopropyl-4-(4-fluorophenyl)-3-Quinolinemethanol (121660-11-5);2-Cyclopropyl-4-(4-fluorophenyl)-3-Quinolinecarboxaldehyde (121660-37-5);2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-MethylBromide (154057-56-4);2-Cyclopropyl-4-(4-flourophenyl)-quinolyl-3-methyl triphenylbromide (154057-58-6);Betaxolol (63659-18-7);Rotigotine (99755-59-6);(S)-2-Amino-5-methoxytetralin (S)-mandelate (439133-67-2);(S)-2-Naphthalenamine,1,2,3,4-tetrahydro-5-methoxy-N-propyl-, hydrochloride (93601-86-6);(S)-2-Naphthalenamine, 1,2,3,4-tetrahydro-5-hydroxy-N-propyl-, hydrobromide (165950-84-5);2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate (160969-03-9);5-[(2R)-2-aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-Indole-7-carbonitrile tartarate (239463-85-5);Ranolazine (95635-55-5);N-2,6-dimethylphenyl-2-chloro acetamide (1131-01-7);1-[N-(2,6-dimethylphenyl)carbamoylmethyl]piperazine (5294-61-1);1-(2-Mthoxyphenoxy)methyl oxirane (2210-74-4)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E10A32

Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals